Skip to main content

Closed

DNLI: Denali Therapeutics Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

71thpctl

Volume

0.64×avg

Market Cap

3.65BUSD

P/E Ratio

-8.0TTM

Div Yield

-ann

Denali Therapeutics Inc.

DNLINASDAQ Global Select·USD·Closed

Denali Therapeutics Inc.

DNLINASDAQ·USD·Closed

$23.02

−5.46%

$23.02

−$1.33 (5.46%)

52W Range

71thpctl

Volume

0.64×avg

Mkt Cap

3.65BUSD

P/E

-8.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings